PUNE, India, April 19, 2024 /PRNewswire/ -- The report titled
"Peptide Therapeutics Market by Technology (Hybrid Phase,
Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic
Hormone, Calcitonin, Insulin), Route of Administration,
Application, End User, Manufacturing Type - Global Forecast
2024-2030" is now available on 360iResearch.com's
offering, presents an analysis indicating that the market projected
to grow from a size of $33.06 billion
in 2023 to reach $57.97 billion by
2030, at a CAGR of 8.35% over the forecast period.
"Advancements in Peptide Therapeutics
Fueling Global Innovations in Disease Treatment"
Peptide therapeutics are emerging as a powerful approach to
combat various diseases, owing to their ability to utilize short
chains of amino acids to effectively target and treat health
conditions. With the prevalence of chronic diseases such as cancer
and diabetes, the need for innovative treatments is more
significant than ever, highlighting the importance of exploring
protein interactions for targeted therapeutic strategies.
Challenges include the instability of peptides and the hefty cost
of production; the field is witnessing a surge in research and
development efforts. This push is prompted by a growing clinical
pipeline filled with promising therapeutic candidates, pointing
toward an era of advanced peptide-based treatments. The Americas
are backed by a solid pharmaceutical foundation and increased
peptide drug approvals, whereas the Asia-Pacific region is rapidly growing, driven
by escalating chronic disease cases, improved healthcare
infrastructure, and heightened awareness of peptide therapeutics.
Europe and the Middle East continue to support innovation
through favorable regulatory policies and significant investment in
research, exhibiting the global market's potential to revolutionize
healthcare with peptide therapeutics.
Download Sample Report
@ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
"The Rising Influence of Peptide
Therapeutics on Non-Surgical Treatments"
Aesthetic dermatology has significantly evolved, with peptide
therapeutics at the forefront of this transformation. These
innovative treatments, particularly signal peptides, are pivotal in
promoting skin collagen production by transitioning toward this
shift of molecular-based cosmetic enhancements. This advancement is
crucial in enhancing skin firmness while minimizing wrinkles,
marking a deviation from traditional, more invasive procedures.
Peptides have become integral to topical applications such as
creams, serums, and gels, addressing anti-aging concerns, improving
skin hydration, and facilitating barrier repair. Furthermore, their
synergy with other dermatological techniques, including chemical
peels and microdermabrasion, accelerates healing and fosters skin
rejuvenation. Amidst rising achievements in the field, the industry
is witnessing substantial investments to boost peptide production
for dermatological purposes, emphasizing the vital role of peptides
in improving non-surgical treatment outcomes and developing new
approaches in patient care within aesthetic dermatology.
"Innovative Hybrid Phase Approach
Revolutionizes Complex Peptide Synthesis"
The cutting-edge hybrid phase approach is transforming the field
of peptide therapeutics by ingeniously merging liquid-phase and
solid-phase synthesis. This groundbreaking method proves superior,
especially when crafting large or intricate peptides, by addressing
the limitations inherent in traditional synthesis strategies. While
liquid-phase peptide synthesis (LPPS) produces small to medium
peptides on a small scale, its solid-phase counterpart assembles
longer, more complicated peptide sequences with remarkable
efficiency and scalability. The hybrid phase technology is
flexible, incorporating the rapidity of liquid-phase techniques in
the initial stages and the robustness of solid-phase methods for
crafting larger, complex structures. This approach enhances the
production efficiency and scalability of peptide synthesis and
ensures the high purity of the final peptides, making it crucial
for researchers and industries focused on developing
next-generation peptide therapeutics.
Request Analyst Support
@ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
"Novo Nordisk A/S at the Forefront of
Peptide Therapeutics Market with a Strong 7.12% Market
Share"
The key players in the Peptide Therapeutics Market include
AstraZeneca PLC, Novo Nordisk A/S, Ipsen Group, GlaxoSmithKline
PLC, Eli Lilly and Company, and others. These prominent players
focus on strategies such as expansions, acquisitions, joint
ventures, and developing new products to strengthen their market
positions.
"Introducing ThinkMi: Revolutionizing
Market Intelligence with AI-Powered Insights for the Peptide
Therapeutics Market"
We proudly unveil ThinkMi, a cutting-edge AI product designed to
transform how businesses interact with the Peptide Therapeutics
Market. ThinkMi stands out as your premier market intelligence
partner, delivering unparalleled insights with the power of
artificial intelligence. Whether deciphering market trends or
offering actionable intelligence, ThinkMi is engineered to provide
precise, relevant answers to your most critical business questions.
This revolutionary tool is more than just an information source;
it's a strategic asset that empowers your decision-making with
up-to-the-minute data, ensuring you stay ahead in the fiercely
competitive Peptide Therapeutics Market. Embrace the future of
market analysis with ThinkMi, where informed decisions lead to
remarkable growth.
Ask Question to ThinkMi
@ https://app.360iresearch.com/library/intelligence/peptide-therapeutics
"Dive into the Peptide Therapeutics Market
Landscape: Explore 194 Pages of Insights, 566 Tables, and 28
Figures"
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Peptide Therapeutics Market, by Technology
- Peptide Therapeutics Market, by Drug Class
- Peptide Therapeutics Market, by Route of Administration
- Peptide Therapeutics Market, by Application
- Peptide Therapeutics Market, by End User
- Peptide Therapeutics Market, by Manufacturing Type
- Americas Peptide Therapeutics Market
- Asia-Pacific Peptide Therapeutics Market
- Europe, Middle East & Africa Peptide Therapeutics
Market
- Competitive Landscape
- Competitive Portfolio
Inquire Before Buying
@ https://www.360iresearch.com/library/intelligence/peptide-therapeutics
Related Reports:
- Constrained Peptide Drugs Market - Global Forecast
2024-2030
- Oral Proteins & Peptides Market - Global Forecast
2024-2030
- Peptide Antibiotics Market - Global Forecast 2024-2030
About 360iResearch
Founded in 2017, 360iResearch is a market research and business
consulting company headquartered in India, with clients and focus markets spanning
the globe.
We are a dynamic, nimble company that believes in carving
ambitious, purposeful goals and achieving them with the backing of
our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes
to market intelligence and volatility. Our market intelligence is
diligent, real-time and tailored to your needs, and arms you with
all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500,
and leading consulting and research companies and academic
institutions that rely on our expertise in compiling data in niche
markets. Our meta-insights are intelligent, impactful and infinite,
and translate into actionable data that support your quest for
enhanced profitability, tapping into niche markets, and exploring
new revenue opportunities.
Contact 360iResearch
Mr. Ketan Rohom
360iResearch Private Limited,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
Email: sales@360iresearch.com
USA: +1-530-264-8485
India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn,
Twitter, and Facebook.
Logo:
https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/peptide-therapeutics-market-projected-to-reach-57-97-billion-by-2030---exclusive-report-by-360iresearch-302121913.html